Reaction
Metastatic Lymphoma reporting signals
As of the last recalculation, Metastatic Lymphoma appears in 389 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is AXICABTAGENE CILOLEUCEL (PRR 78.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Axicabtagene Ciloleucel | 14 | 78.7 | 78.8 |
| Polatuzumab Vedotin | 9 | 50.5 | 50.5 |
| Melphalan | 15 | 36.7 | 36.7 |
| Melphalan Hydrochloride | 15 | 33.3 | 33.3 |
| Bendamustine Hcl | 7 | 24.6 | 24.6 |
| Gemcitabine | 17 | 24.1 | 24.1 |
| Gemcitabine Hydrochloride | 19 | 20.1 | 20.1 |